Finally, while a competing mechanism maybe hypothesized between adiponectin and leptin in preventing or inducing liver damage in the course of NAFLD, data in regard of ASH are inconclusive and suggest a modest influence of these adipokines in alcohol‐related liver disease in human. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.